Adamas Pharmaceuticals: Adrian Quartel, chief medical officer
Adamas Pharmaceuticals, a company focused on neurological therapies, has appointed Adrian Quartel as chief medical officer. In his new role, Quarter is charged with leading the firm and providing direction for all scientific and medical functions.
“We are delighted to welcome Adrian to our leadership team to further accelerate the progress and execution of our long-term growth strategy,” said CEO Neil McFarlane. “His proven track record in drug development and extensive clinical experience will be especially valuable at this pivotal time as we build our development efforts to expand our reach to more patients.”
